These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Multiple myeloma: an overview for the clinician. Klos JR; Bortz JW J Am Osteopath Assoc; 1979 Oct; 79(2):113-9. PubMed ID: 489441 [No Abstract] [Full Text] [Related]
4. The clinical and pathologic spectrum of multiple myeloma. Kapadia SB Compr Ther; 1984 Jan; 10(1):46-51. PubMed ID: 6362971 [No Abstract] [Full Text] [Related]
5. The cyclic use of multiple alkylating agents in multiple myeloma. Harley JB; Ramanan SV; Kim I; Thiagarajan PV; Chen JH; Gomez R; Koppel D; Hyde F; Gustke S; Krall J W V Med J; 1972 Jan; 68(1):1-3. PubMed ID: 4500402 [No Abstract] [Full Text] [Related]
6. Long-term survival in multiple myeloma. Kyle RA N Engl J Med; 1983 Feb; 308(6):314-6. PubMed ID: 6823231 [No Abstract] [Full Text] [Related]
7. [Effect of the manner of the response to chemotherapy on the prognosis of myeloma. Preliminary study]. Bataille R; Morlock G; Sany J; Blotman F; Simon L Rev Rhum Mal Osteoartic; 1981 May; 48(5):413-8. PubMed ID: 7256151 [TBL] [Abstract][Full Text] [Related]
9. Evaluation and treatment of multiple myeloma and related disorders. Salmon SE Ariz Med; 1974 Sep; 31(9):660-3. PubMed ID: 4213094 [No Abstract] [Full Text] [Related]
10. [Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents]. Bernardeschi P; Urbano U Haematologica; 1983; 68(5):684-8. PubMed ID: 6416948 [No Abstract] [Full Text] [Related]
11. Therapeutic progress--review XII. Treatment of multiple myeloma. Oakley JE; Franklin IM J Clin Hosp Pharm; 1984 Mar; 9(1):15-20. PubMed ID: 6371060 [No Abstract] [Full Text] [Related]
12. [Prognostic factors and standard therapy of multiple myeloma]. Peest D Praxis (Bern 1994); 1998 Jun; 87(25-26):874-8. PubMed ID: 9702090 [TBL] [Abstract][Full Text] [Related]
13. Advances in the treatment of multiple myeloma. Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186 [No Abstract] [Full Text] [Related]
14. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation. Weber DM Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120 [TBL] [Abstract][Full Text] [Related]
15. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma. Stölting T; Knauerhase H; Klautke G; Kundt G; Fietkau R Strahlenther Onkol; 2008 Sep; 184(9):465-72. PubMed ID: 19016025 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of multiple myeloma]. La Verde G; Pulsoni A; Petrucci MT; Mandelli F Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817 [TBL] [Abstract][Full Text] [Related]
17. [The effect of alkylating cytostatics on the development of secondary malignant tumors]. Galajda P; Donner L Vnitr Lek; 1984 Aug; 30(8):756-63. PubMed ID: 6506498 [No Abstract] [Full Text] [Related]
18. [Multiple myelomas. IV. Treatment and prognosis]. Hoerni B; Durand M; Chauvergne J Bord Med; 1972 Jun; 5(11):1273-9. PubMed ID: 4115503 [No Abstract] [Full Text] [Related]